April 2009
Volume 50, Issue 13
ARVO Annual Meeting Abstract  |   April 2009
Genetic Studies of Macular Telangiectasia
Author Affiliations & Notes
  • N. L. Parmalee
    Genetics and Development,
    Columbia University, New York, New York
  • C. Schubert
    Columbia University, New York, New York
  • C. Toomes
    Molecular Medicine Unit, University of Leeds, West Yorkshire, United Kingdom
  • J. Merriam
    Columbia University, New York, New York
  • M. Gillies
    Clinical Ophthalmology and Eye Health, The University of Sydney, Sydney, Australia
  • R. Allikmets
    Ophthalmology, Pathology,
    Columbia University, New York, New York
  • The MacTel Project
    Columbia University, New York, New York
  • Footnotes
    Commercial Relationships  N.L. Parmalee, None; C. Schubert, None; C. Toomes, None; J. Merriam, None; M. Gillies, None; R. Allikmets, None.
  • Footnotes
    Support  The MacTel Project, NEI Vision Sciences Training Grant
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 2814. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. L. Parmalee, C. Schubert, C. Toomes, J. Merriam, M. Gillies, R. Allikmets, The MacTel Project; Genetic Studies of Macular Telangiectasia. Invest. Ophthalmol. Vis. Sci. 2009;50(13):2814.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Macular telangiectasia type 2 (MacTel) is a relatively rare retinal disease characterized by the presence of telangiectatic vessels, loss of macular pigment, and, eventually, vision. Since familial aggregation suggests a strong genetic component in this disease, this study was undertaken to find the causal gene(s) for MacTel.

Methods: : Samples were collected from 202 MacTel patients, including 36 individuals in 15 families. Candidate genes were identified based on function in angiogenesis and macular pigment transport, differential expression in retinal vessels, and from known genes in diseases with similar phenotype. Probands from 8 families were screened for variants in the APJ, Apelin, FZD4, NDP, LRP5, DKK1, ANG1, TIE2, VLDLR, and GSTP1 genes by direct sequencing; if applicable, segregation analyses were performed in families and variant frequencies determined by Taqman assays.

Results: : Six missense variants were found in 4 genes: Tie2, LRP5, FZD4 and GSTP1. Of those, the P33S variant in FZD4 had been described before as causal in FEVR. This variant was identified in one MacTel patient in another study and subsequently found in four patients in our cohort. However, this variant did not segregate with the disease in MacTel families and was detected in 2-3% of the general population of Caucasian origin. Therefore, the P33S variant was excluded as a possibly causal mutation in both MacTel and FEVR. The Tie2, LRP5 and GSTP1 variants also did not segregate with disease in the families.

Conclusions: : No apparent disease-associated mutations were found in ten screened candidate genes for MacTel. However, some of these variants are under further evaluation for potential modifying effects. Candidate gene screening and genome-wide linkage and association studies are underway.

Keywords: gene screening • retinal degenerations: hereditary • genetics 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.